The role of anti-tumor necrosis factor receptor agents in cancer survivors: does the risk justify the benefit?Paul Chapman,Lee Cranmer,W G Dixon,K L Hyrich,John R Patterson,D P M Symmons,Mary Toporcer,Michael J MastrangeloSeminars in Oncology(2010)引用 3|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要